SCHEMBL13048990

SCHEMBL13048990

CCCC(NC(=O)OC)C(=O)CC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 6/20 0.40
CTSS P25774 2/20 0.40
EPHX1 P07099 1/20 0.34
TAS1R3 Q7RTX0 3/20 0.33
TAS1R1 Q7RTX1 3/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
HDAC9 Q9UKV0 1/20 0.33
HDAC5 Q9UQL6 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
TGFBR1 P36897 1/20 0.32
CHRM1 P11229 1/20 0.32
AKR1A1 P14550 1/20 0.32
CHRM3 P20309 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
ADRA1A P35348 1/20 0.32
HRH1 P35367 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12175194 1.00 CTSK (0.40) CTSKCTSSEPHX1TAS1R3TAS1R1
SCHEMBL19364767 0.86 CTSK (0.39) CTSKCTSSEPHX1TAS1R3TAS1R1
SCHEMBL8915362 0.85 GAA (0.31)
SCHEMBL21896885 0.85 GAA (0.31)
SCHEMBL8921735 0.83 CTSK (0.37) CTSKCTSSEPHX1CA1CA2
SCHEMBL8915388 0.83 CTSK (0.37) CTSKCTSSEPHX1CA1CA2
SCHEMBL15355010 0.83 CTSK (0.37) CTSKCTSSEPHX1CA1CA2
SCHEMBL19485900 0.82 GAA (0.35) CTSKCTSSCA1CA2
SCHEMBL14865102 0.82 L3MBTL1 (0.43) CTSKCTSSTAS1R3TAS1R1CYP3A4
SCHEMBL20643810 0.82 L3MBTL1 (0.43) CTSKCTSSTAS1R3TAS1R1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9796705-B2 Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases MERCK SHARP & DOHME CORP. (US) 2017-10-24 US disclosed
EP-2430015-B1 FUSED TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF VIRAL DISEASES MERCK SHARP & DOHME (US) 2015-06-17 EP disclosed
EP-2368890-B9 Hepatitis C virus inhibitors ABBVIE BAHAMAS LTD (BS) 2013-10-30 EP disclosed
EP-2368890-B1 Hepatitis C virus inhibitors ABBVIE BAHAMAS LTD (BS) 2013-04-17 EP disclosed
WO-2010138790-A1 ANTIVIRAL COMPOUNDS COMPOSED OF THREE ALIGNED ARYL MOIETIES TO TREAT DISEASES SUCH AS HEPATITIS C SCHERING CORPORATION (US) 2010-12-02 WO disclosed